source
- iECURE’s early gene-therapy success in a baby fails to replicate in larger trialEarly last year iECURE reported that its experimental gene therapy appeared to cure an infant suffering from a severe genetic disorder. The company has now released data from a follow-up study tha…
- FDA grants accelerated approval to sonrotoclax for relapsed/refractory mantle cell lymphomaThe U.S. Food and Drug Administration has granted accelerated approval to sonrotoclax (brand name Beqalzi) for adult patients with relapsed or refractory mantle cell lymphoma who have received at l…